Is pharmaceutical R&D just a game of chance or can strategy make a difference?

被引:20
作者
Schmid, EF [1 ]
Smith, DA [1 ]
机构
[1] Sandwich Labs, PGRD, Sandwich CT13 9NJ, Kent, England
关键词
D O I
10.1016/S1359-6446(04)02951-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmaceutical industry is currently experiencing turbulent, yet exciting times. Despite widely expressed negative sentiments regarding productivity there are now signs that innovation could yet win the day and bring a fresh wave of breakthrough drugs. Nowhere is this truer than for oncology, which previously was dominated by cytotoxic drugs. Today, however, this field shows exciting progress with the emergence of kinase inhibitors, as well as various antibody-based mechanistic approaches. Similarly, new drug mechanisms have transformed HIV therapy. Are these chance events, or have they come about through strategy? Here, we argue that a complex interplay of chance and strategy is at work in pharmaceutical R&D, separated in time by 10 years or more.
引用
收藏
页码:18 / 26
页数:9
相关论文
共 14 条
  • [1] ACHILLADELIS B, 1999, PHARM INNOVATION REV, P18
  • [2] *ASTR, 2003, ASTR REV FDA APPR NE
  • [3] Beresford AP, 2002, DRUG DISCOV TODAY, V7, P109
  • [4] Glivec (ST1571, Imatinib), a rationally developed, targeted anticancer drug
    Capdeville, R
    Buchdunger, E
    Zimmermann, J
    Matter, A
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (07) : 493 - 502
  • [5] Strategic trends in the drug industry
    Drews, J
    [J]. DRUG DISCOVERY TODAY, 2003, 8 (09) : 411 - 420
  • [6] EARL MJ, 1981, INFORMATION SYSTEMS
  • [7] New estimates of drug development costs
    Frank, RG
    [J]. JOURNAL OF HEALTH ECONOMICS, 2003, 22 (02) : 325 - 330
  • [8] GILMARTIN RV, 2002, CLOSING REMARKS ANN
  • [9] Grant RM., 2002, Contemporary strategy analysis
  • [10] Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
    Lipinski, CA
    Lombardo, F
    Dominy, BW
    Feeney, PJ
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) : 3 - 25